CIK 0001517022 · Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208756903
- Phone
- 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 34 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-06-10 | Clayman Michael D. Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2015-06-10 | Dalal Anupam Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2015-06-10 | GOWEN MAXINE Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2015-06-10 | Nash Duane Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2015-06-10 | Renaud Ronald C JR Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2015-06-10 | Satter Muneer A Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2015-06-10 | WYZGA MICHAEL S Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2015-05-26 | Butler John P. CEO and President | Option exercise | +50,000 | $0.47 | $24K | 198,350 |
| 2015-05-26 | Butler John P. CEO and President | Option exercise · Stock Option (Right to Buy) | −50,000 | 0 | ||
| 2015-04-22 | Satter Muneer A Director | Purchase | +420,000 | $8.25 | $3.5M | 2,002,560 |
| 2015-04-02 | Hadas Nicole R. SVP, General Counsel, Sec. | Sale | −1,483 | $9.09 | $13K | 67,015 |
| 2015-04-02 | Nash Duane Director | Sale | −996 | $9.09 | $9K | 12,016 |
| 2015-04-02 | Nash Duane Director | Sale | −996 | $9.09 | $9K | 12,016 |
| 2015-04-02 | Hadas Nicole R. SVP, General Counsel, Sec. | Sale | −1,483 | $9.09 | $13K | 76,093 |
| 2015-04-01 | Nash Duane Director | Grant or award | +1,980 | $9.51 | $19K | 13,012 |
| 2015-04-01 | Nash Duane Director | Grant or award | +1,980 | $9.51 | $19K | 13,012 |
| 2015-04-01 | Hadas Nicole R. SVP, General Counsel, Sec. | Grant or award | +4,539 | $9.51 | $43K | 77,576 |
| 2015-03-09 | Butler John P. CEO and President | Option exercise | +100,000 | $0.47 | $47K | 148,350 |
| 2015-03-09 | Butler John P. CEO and President | Option exercise · Stock Option (Right to Buy) | −100,000 | 0 | ||
| 2015-03-06 | Maroni Bradley SVP and Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 |
Page 26 of 27 · 537 trades